Validation of the Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and Inferences

Eitemau Tebyg

• Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
  gan: Sorror, Mohamed L., et al.
  Cyhoeddwyd: (2005)
• Multi-center validation of the prognostic value of the hematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic hematopoietic cell transplantation
  gan: ElSawy, Mahmoud, et al.
  Cyhoeddwyd: (2015)
• Role of Comorbidities in Optimizing Decision-Making for Allogeneic Hematopoietic Cell Transplantation
  gan: Sorror, Mohamed L., et al.
  Cyhoeddwyd: (2010)
• Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pre-transplant Ferritin, Albumin and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation
  gan: Vaughn, Jennifer E., et al.
  Cyhoeddwyd: (2015)
• Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources
  gan: Elsawy, Mahmoud, et al.
  Cyhoeddwyd: (2018)